9th Circ. Probes Buyers On HIV Drug Antitrust Claims

By Matthew Perlman · October 9, 2025, 9:10 PM EDT

Insurers and health plans told a Ninth Circuit panel on Thursday that a lower court was wrong to toss their claims that Gilead orchestrated a product-hop scheme for its HIV drugs...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login